Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2013, Article ID 804675, 6 pages
http://dx.doi.org/10.1155/2013/804675
Review Article

Lymphedema and Therapeutic Lymphangiogenesis

1Department of Vascular Surgery, Asahikawa Medical University, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido 078-8510, Japan
2Division of Vascular Medicine and Epigenetics, Department of Child Development, United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan
3Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
4Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan

Received 19 August 2013; Accepted 13 September 2013

Academic Editor: Ken Suzuki

Copyright © 2013 Yukihiro Saito et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. H. Witte, M. J. Bernas, C. P. Martin, and C. L. Witte, “Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology,” Microscopy Research and Technique, vol. 55, no. 2, pp. 122–145, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Oliver and M. Detmar, “The rediscovery of the lymphatic system: old and new insights into the development and biological function of the lymphatic vasculature,” Genes and Development, vol. 16, no. 7, pp. 773–783, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Jeltsch, T. Tammela, K. Alitalo, and J. Wilting, “Genesis and pathogenesis of lymphatic vessels,” Cell and Tissue Research, vol. 314, no. 1, pp. 69–84, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Küchler, E. Gjini, J. Peterson-Maduro, B. Cancilla, H. Wolburg, and S. Schulte-Merker, “Development of the zebrafish lymphatic system requires Vegfc signaling,” Current Biology, vol. 16, no. 12, pp. 1244–1248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ny, M. Koch, M. Schneider et al., “A genetic Xenopus laevis tadpole model to study lymphangiogenesis,” Nature Medicine, vol. 11, no. 9, pp. 998–1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Yaniv, S. Isogai, D. Castranova, L. Dye, J. Hitomi, and B. M. Weinstein, “Live imaging of lymphatic development in the zebrafish,” Nature Medicine, vol. 12, no. 6, pp. 711–716, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. B. De Almeida and D. O. Freedman, “Epidemiology and immunopathology of bancroftian filariasis,” Microbes and Infection, vol. 1, no. 12, pp. 1015–1022, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Szuba and S. G. Rockson, “Lymphedema: classification, diagnosis and therapy,” Vascular Medicine, vol. 3, no. 2, pp. 145–156, 1998. View at Google Scholar · View at Scopus
  9. L. T. Kurland and C. A. Molgaard, “The patient record in epidemiology,” Scientific American, vol. 245, no. 4, pp. 54–63, 1981. View at Google Scholar · View at Scopus
  10. D. M. Smeltzer, G. B. Stickler, and A. Schirger, “Primary lymphedema in children and adolescents: a follow-up study and review,” Pediatrics, vol. 76, no. 2, pp. 206–218, 1985. View at Google Scholar · View at Scopus
  11. T. DiSipio, S. Rye, B. Newman, and S. Hayes, “Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis,” The Lancet Oncology, vol. 14, no. 6, pp. 500–515, 2013. View at Google Scholar
  12. Y. Ohba, Y. Todo, N. Kobayashi et al., “Risk factors for lower-limb lymphedema after surgery for cervical cancer,” International Journal of Clinical Oncology, vol. 16, no. 3, pp. 238–243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Tada, S. Teramukai, M. Fukushima, and H. Sasaki, “Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma,” BMC Cancer, vol. 9, article 47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Beesley, M. Janda, E. Eakin, A. Obermair, and D. Battistutta, “Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs,” Cancer, vol. 109, no. 12, pp. 2607–2614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. N. Cormier, R. L. Askew, K. S. Mungovan, Y. Xing, M. I. Ross, and J. M. Armer, “Lymphedema beyond breast cancer,” Cancer, vol. 116, no. 22, pp. 5138–5149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D. S. C. Ko, R. Lerner, G. Klose, and A. B. Cosimi, “Effective treatment of lymphedema of the extremities,” Archives of Surgery, vol. 133, no. 4, pp. 452–458, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Girgis, F. Stacey, T. Lee, D. Black, and S. Kilbreath, “Priorities for women with lymphoedema after treatment for breast cancer: population based cohort study,” BMJ, vol. 342, Article ID d3442, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. International Society of Lymphology, “The diagnosis and treatment of peripheral lymphedema,” Lymphology, vol. 42, no. 2, pp. 51–60, 2009. View at Google Scholar
  19. T. M. Maher, A. U. Wells, and G. J. Laurent, “Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?” European Respiratory Journal, vol. 30, no. 5, pp. 835–839, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. N. L. Harvey, R. S. Srinivasan, M. E. Dillard et al., “Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity,” Nature Genetics, vol. 37, no. 10, pp. 1072–1081, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Kamei, K. Tobe, R. Suzuki et al., “Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance,” Journal of Biological Chemistry, vol. 281, no. 36, pp. 26602–26614, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Suganami and Y. Ogawa, “Adipose tissue macrophages: their role in adipose tissue remodeling,” Journal of Leukocyte Biology, vol. 88, no. 1, pp. 33–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. N. Cueni and M. Detmar, “New insights into the molecular control of the lymphatic vascular system and its role in disease,” Journal of Investigative Dermatology, vol. 126, no. 10, pp. 2167–2177, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Karpanen and K. Alitalo, “Molecular biology and pathology of lymphangiogenesis,” Annual Review of Pathology, vol. 3, pp. 367–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. F. W. Stewart and N. Treves, “Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica,” Cancer, vol. 1, no. 1, pp. 64–81, 1948. View at Google Scholar · View at Scopus
  26. C. Heitmann and G. Ingianni, “Stewart-Treves syndrome: lymphangiosarcoma following mastectomy,” Annals of Plastic Surgery, vol. 44, no. 1, pp. 72–75, 2000. View at Google Scholar · View at Scopus
  27. L. Jussila and K. Alitalo, “Vascular growth factors and lymphangiogenesis,” Physiological Reviews, vol. 82, no. 3, pp. 673–700, 2002. View at Google Scholar · View at Scopus
  28. M. J. Karkkainen, P. Haiko, K. Sainio et al., “Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins,” Nature Immunology, vol. 5, no. 1, pp. 74–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Mäkinen, L. Jussila, T. Veikkola et al., “Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3,” Nature Medicine, vol. 7, no. 2, pp. 199–205, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. Y.-S. Yoon, T. Murayama, E. Gravereaux et al., “VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema,” Journal of Clinical Investigation, vol. 111, no. 5, pp. 717–725, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Morisada, Y. Oike, Y. Yamada et al., “Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation,” Blood, vol. 105, no. 12, pp. 4649–4656, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. L. K. Chang, G. Garcia-Cardeña, F. Farnebo et al., “Dose-dependent response of FGF-2 for lymphangiogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 32, pp. 11658–11663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Nakamura, R. Morishita, J. Higaki et al., “Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor,” Journal of Hypertension, vol. 14, no. 9, pp. 1067–1072, 1996. View at Google Scholar · View at Scopus
  34. E. Van Belle, B. Witzenbichler, D. Chen et al., “Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis,” Circulation, vol. 97, no. 4, pp. 381–390, 1998. View at Google Scholar · View at Scopus
  35. D. A. Rappolee, A. Iyer, and Y. Patel, “Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis,” Circulation Research, vol. 78, no. 6, pp. 1028–1036, 1996. View at Google Scholar · View at Scopus
  36. Y. Taniyama, R. Morishita, H. Nakagami et al., “Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters,” Circulation, vol. 102, no. 2, pp. 246–252, 2000. View at Google Scholar · View at Scopus
  37. W. Jung, E. Castren, M. Odenthal et al., “Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain,” Journal of Cell Biology, vol. 126, no. 2, pp. 485–494, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Taniyama, R. Morishita, M. Aoki et al., “Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy,” Hypertension, vol. 40, no. 1, pp. 47–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Aoki, R. Morishita, Y. Taniyama, Y. Kaneda, and T. Ogihara, “Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases,” Journal of atherosclerosis and thrombosis, vol. 7, no. 2, pp. 71–76, 2000. View at Google Scholar · View at Scopus
  40. H. Koike, A. Ishida, M. Shimamura et al., “Prevention of onset of Parkinson's disease by in vivo gene transfer of human hepatocyte growth factor in rodent model: a model of gene therapy for Parkinson's disease,” Gene Therapy, vol. 13, no. 23, pp. 1639–1644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Watanabe, M. Ebina, F. M. Orson et al., “Hepatocyte growth factor gene transfer to alveolar septa for effective suppression of lung fibrosis,” Molecular Therapy, vol. 12, no. 1, pp. 58–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Bussolino, M. F. Di Renzo, M. Ziche et al., “Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth,” Journal of Cell Biology, vol. 119, no. 3, pp. 629–641, 1992. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Graziani, D. Gramaglia, L. C. Cantley, and P. M. Comoglio, “The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase,” Journal of Biological Chemistry, vol. 266, no. 33, pp. 22087–22090, 1991. View at Google Scholar · View at Scopus
  44. A. Graziani, D. Gramaglia, P. Dalla Zonca, and P. M. Comoglio, “Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger,” Journal of Biological Chemistry, vol. 268, no. 13, pp. 9165–9168, 1993. View at Google Scholar · View at Scopus
  45. Y. Saito, H. Nakagami, R. Morishita et al., “Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis,” Circulation, vol. 114, no. 11, pp. 1177–1184, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. R. Morishita, M. Aoki, N. Hashiya et al., “Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease,” Hypertension, vol. 44, no. 2, pp. 203–209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Isner, A. Pieczek, R. Schainfeld et al., “Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb,” The Lancet, vol. 348, no. 9024, pp. 370–374, 1996. View at Publisher · View at Google Scholar · View at Scopus